DexCom, Inc. (DXCM)
-NasdaqGS | Prev Close: | 21.44 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 18.32 |
|---|
| Beta: | 0.5 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 10.65 - 22.97 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 520,688 |
|---|
| Market Cap: | 1.52B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.74 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why DexCom May Be About to Take Offat Motley Fool(Mon, Jun 17)
- Dexcom downgraded by Feltl & Co.Briefing.com(Thu, Jun 13)
- Here's Why DexCom's Earnings Are Worse Than They Lookat Motley Fool(Mon, Jun 10)
- DexCom downgraded to Hold from Buy at Wunderlichtheflyonthewall.com(Mon, Jun 10)
- 3 Stocks Near 52-Week Highs Worth Sellingat Motley Fool(Thu, Jun 6)
- DEXCOM INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Tue, Jun 4)
- DexCom to Present at William Blair Growth Stock ConferenceBusiness Wire(Tue, Jun 4)
- DexCom's Management Presents at Deutsche Bank dbAccess Health Care Conference (Transcript)at Seeking Alpha(Wed, May 29)
- DexCom Stays at NeutralZacks(Thu, May 23)
- Medical Products Companies, Particularly Those Aimed at Surgical Procedures, Generating Substantial Free Cash and Showing High Returns on CapitalWall Street Transcript(Fri, May 17)
- DexCom's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Thu, May 16)
- 5 Stocks This Growth-Oriented Hedge Fund Is Most Committed Toat Seeking Alpha(Sun, May 12)
- DexCom Announces Upcoming PresentationsBusiness Wire(Thu, May 9)
- DEXCOM INC FinancialsEDGAR Online Financials(Wed, May 8)
- 2 Winners and 3 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sat, May 4)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| DXCM | 0.00% | 1.52B |
| BAX | 0.00% | 37.75B |
| COV | 0.00% | 29.91B |
| CSRT.L | 0.44% | 229.43M |
| BDX | 0.00% | 19.19B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 13.86 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.56 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.16 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | -1.25 |
|---|
Business Summary
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare provid...
View More